Under the theme “Multimodal Management of Musculoskeletal Patients in the Era of Multimodal Treatment,” the conference brought together approximately 350–400 healthcare professionals, including professors, doctors, pharmacists and specialists from various disciplines. The scientific programme featured 8 sessions with 27–28 presentations, covering both clinical research and practical case reports.
The conference focused on multimodal and multidisciplinary approaches to the diagnosis and management of musculoskeletal conditions, including rheumatoid arthritis, spondyloarthritis, gout, systemic lupus erythematosus, osteoarthritis and osteoporosis, as well as less common conditions such as systemic sclerosis, autoimmune myopathies and connective tissue disease-associated interstitial lung disease.
Bridge Healthcare Representative Office and Alter Pharma Co., Ltd. were pleased to accompany the conference and introduce quality healthcare products to participating healthcare professionals, contributing to professional knowledge exchange and the advancement of musculoskeletal healthcare.
